Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Neuroblastoma 5Medulloblastoma 5Carcinoma 4Mouth Neoplasms 3Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Ganglioneuroblastoma 3Vulvar Neoplasms 2Stomach Neoplasms 2Oropharyngeal Neoplasms 2Gallbladder Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Vomiting 1Urinary Bladder Neoplasms 1Teratoma 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Sertoli-Leydig Cell Tumor 1Rhabdoid Tumor 1Recurrent Uterine Corpus Carcinoma 1Papillomavirus Infections 1Ovarian gynandroblastoma 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasms, Germ Cell and Embryonal 1Neoplasm Metastasis 1Nausea 1Lymphoid Interstitial Pneumonia 1

Interventions

Filgrastim 4Etoposide 4Ifosfamide 3Cisplatin 3Carboplatin 3Bleomycin 3Specimen Handling 2Peripheral Blood Stem Cell Transplantation 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Granulocyte Colony-Stimulating Factor 2pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1liposomal amphotericin B 1Thiotepa 1Taxes 1Standard of Care 1Second-Look Surgery 1Respiratory Physiological Phenomena 1Reoperation 1Radiotherapy 1Radiation 1Practice Guidelines as Topic 1Platinum 1Mesna 1Immunohistochemistry 1Biopsy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Carcinoma, Embryonal × Platinum × Clear all
NCT03067181 2026-05-05

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Children's Oncology Group

Phase 3 Recruiting
1,780 enrolled

Neoplasms, Germ Cell and Embryonal, Teratoma, Carcinoma, Embryonal, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡